Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2011

Jun 14, 2011

30786_dirs_2011-06-14_3cb844d0-48df-42f4-852b-5b850a5ffd89.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2011-06-10

Reporting Person: SCHWARTZ ALICE N (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-06-10 Bio-Rad B Common Stock M 334 Acquired 463224 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-06-10 Restricted Stock Units $ M 334 Disposed Bio-Rad B Common Stock (334) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 2094158 Direct
Bio-Rad A Common Stock 480423 Indirect
Bio-Rad A Common Stock 480423 Indirect
Bio-Rad A Common Stock 34311 Indirect
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 41176 Indirect

Footnotes

F1: The shares are held by a limited partnership of which the reporting person is a limited and general partner.

F2: The shares are held by a limited partnership of which the reporting person is a general partner.

F3: Shares of Class B common stock acquired upon the vesting of restricted stock units by spouse. Reporting person is the spouse of David Schwartz, Chairman of the Board of Bio-Rad Laboratories and beneficial owner of more than 10% of the Company's common stock

F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.

F5: The restriced stock units vest in five equal annual installments beginning June 10, 2010.